CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Immunovant Inc IMVT
$33.23
▼ -1.77%
($-0.60)
Open
$33.99
Prev Close
$33.83
Day Range
$33.14 – $34.63
52W Range
$13.79 – $36.29
Market Cap
$6.95B
Beta
0.79
EPS (TTM)
$-2.77
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-14 |
| Shares Out. | 203,530,000 |
| Website | immunovant.com/ ↗ |
| Phone | 13026365400 |
Immunovant Inc is a publicly traded company under the ticker symbol IMVT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for IMVT
Guggenheim Maintains Buy on Immunovant, Raises Price Target to $62
Immunovant: Upgraded To 'Buy' Because Of IMVT-1402's Broad Potential
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Truist Securities Maintains Hold on Immunovant, Raises Price Target to $30